Evaluation of Therapeutic Strategies in Pediatric Cataract Surgery (EP3C)

November 17, 2025 updated by: Assistance Publique - Hôpitaux de Paris

Assessment Practices Registry in Congenital Cataract Surgery and Infantile

The purpose of this observational study is to assess the therapeutic strategies in the treatment of pediatric cataracts.

Study Overview

Status

Withdrawn

Conditions

Detailed Description

Technical progress and recently described potential issues have recently challenged the surgical treatment of pediatric cataracts. Many questions remain unsolved: primary vs secondary implantation, nature of the implant used. The aim of this study is to establish a systematic prospective register of all cataracts operated on in a tertiary pediatric centre in order to help answering these questions.

Study Type

Observational

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Paris, France, 75015
        • Hospital Necker - Enfants Malades (Assistance Publique-Hôpitaux de Paris)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 second to 17 years (Child)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

ophthalmology department, Necker hospital.

Description

Inclusion Criteria:

  • Child cataract surgery from 1 September 2014 in the Department of Ophthalmology, University Hospital Necker-Enfants Malades
  • Children aged between 0 and 17 years
  • Child with unilateral or bilateral cataract

Exclusion Criteria:

  • Child with bilateral cataract, one eye having previously been operated in another center.
  • Children whose parents have notified the doctor their refusal of data collection

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Children operated on for cataract
Compilation of results of monitoring of children aged 8 to 10 months, 3 years, 5 years, 8 years

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assessment practices in Pediatric Cataract Surgery.
Time Frame: 8-10 months,
  • Rating of efficacy of surgery depending on the implementation or not of a primary location
  • Evaluate the effectiveness of the implementation based on the type of implant (monofocal or multifocal)
  • Evaluation of effectiveness of surgery based on age (<8 weeks of age for unilateral surgery and <11 weeks of life for bilateral surgeries)
  • To assess the frequency of adverse events, particularly glaucoma depending on the occurrence or non-implementation of a primary
8-10 months,
Assessment practices in Pediatric Cataract Surgery.
Time Frame: 3 years
  • Rating of efficacy of surgery depending on the implementation or not of a primary location
  • Evaluate the effectiveness of the implementation based on the type of implant (monofocal or multifocal)
  • Evaluation of effectiveness of surgery based on age (<8 weeks of age for unilateral surgery and <11 weeks of life for bilateral surgeries)
  • To assess the frequency of adverse events, particularly glaucoma depending on the occurrence or non-implementation of a primary
3 years
Assessment practices in Pediatric Cataract Surgery.
Time Frame: 5 years
  • Rating of efficacy of surgery depending on the implementation or not of a primary location
  • Evaluate the effectiveness of the implementation based on the type of implant (monofocal or multifocal)
  • Evaluation of effectiveness of surgery based on age (<8 weeks of age for unilateral surgery and <11 weeks of life for bilateral surgeries)
  • To assess the frequency of adverse events, particularly glaucoma depending on the occurrence or non-implementation of a primary
5 years
Assessment practices in Pediatric Cataract Surgery.
Time Frame: 8 years (or 6 months after surgery if the child is carried out after 8 years )
  • Rating of efficacy of surgery depending on the implementation or not of a primary location
  • Evaluate the effectiveness of the implementation based on the type of implant (monofocal or multifocal)
  • Evaluation of effectiveness of surgery based on age (<8 weeks of age for unilateral surgery and <11 weeks of life for bilateral surgeries)
  • To assess the frequency of adverse events, particularly glaucoma depending on the occurrence or non-implementation of a primary
8 years (or 6 months after surgery if the child is carried out after 8 years )

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Type of surgery and surgical procedures
Time Frame: 8-10 months
8-10 months
Type of surgery and surgical procedures
Time Frame: 3 years
3 years
Type of surgery and surgical procedures
Time Frame: 5 years
5 years
Type of surgery and surgical procedures
Time Frame: 8 years (or 6 months after surgery if the child is carried out after 8 years).
8 years (or 6 months after surgery if the child is carried out after 8 years).
8 years (or 6 months after surgery if the child is carried out after 8 years).
Type of implant
Time Frame: 8-10 months
8-10 months
Type of implant
Time Frame: 3 years
3 years
Type of implant
Time Frame: 5 years
5 years
Type of implant
Time Frame: 8 years (or 6 months after surgery if the child is carried out after 8 years).
8 years (or 6 months after surgery if the child is carried out after 8 years).
Age at implantation
Time Frame: 8-10 months,
8-10 months,
Age at implantation
Time Frame: 3 years,
3 years,
Age at implantation
Time Frame: 5 years
5 years
Age at implantation
Time Frame: 8 years (or 6 months after surgery if the child is carried out after 8 years).
8 years (or 6 months after surgery if the child is carried out after 8 years).
Distance visual acuity
Time Frame: age of 8 years and 6 months after surgery if the child is carried out after the age of 8.
age of 8 years and 6 months after surgery if the child is carried out after the age of 8.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Matthieu Robert, MD, Hôpital Necker - Enfants Malades, Assistance Publique-Hôpitaux de Paris, France

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 1, 2014

Primary Completion (Estimated)

December 1, 2015

Study Completion (Actual)

December 1, 2015

Study Registration Dates

First Submitted

September 26, 2014

First Submitted That Met QC Criteria

September 26, 2014

First Posted (Estimated)

October 1, 2014

Study Record Updates

Last Update Posted (Actual)

November 20, 2025

Last Update Submitted That Met QC Criteria

November 17, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2014-06-13

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cataract

Clinical Trials on Children operated on for cataract

Subscribe